GI Innovation’s anti-aging therapy reaches XPRIZE final

GI Innovation said Wednesday it and its affiliate GI Longevity have advanced to the finals of the XPRIZE Healthspan competition as their anti-aging therapy has been recognized for its potential therapeutic uses. XPRIZE Healthspan — a seven-year global competition with a total prize pool of $101 million — seeks to develop therapies capable of restoring muscle, cognitive and immune functions in adults aged 50 to 80 by at least 10 years, with a goal of achieving improvements equivalent to 20 years